 Judith Blaine
Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Podocytes | 9 | 2023 | 44 | 5.450 |
Why?
| | Receptors, Fc | 6 | 2023 | 45 | 3.010 |
Why?
| | Histocompatibility Antigens Class I | 5 | 2023 | 172 | 2.250 |
Why?
| | Actin Cytoskeleton | 2 | 2020 | 93 | 1.300 |
Why?
| | Serum Albumin | 3 | 2019 | 137 | 1.140 |
Why?
| | Albumins | 3 | 2021 | 89 | 1.030 |
Why?
| | Phosphates | 6 | 2022 | 159 | 0.990 |
Why?
| | Kidney Tubules, Proximal | 5 | 2022 | 113 | 0.970 |
Why?
| | Endocytosis | 3 | 2014 | 148 | 0.930 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIa | 4 | 2022 | 9 | 0.850 |
Why?
| | Parathyroid Hormone | 4 | 2022 | 96 | 0.810 |
Why?
| | Lysosomes | 4 | 2023 | 123 | 0.800 |
Why?
| | Immunoglobulin G | 3 | 2023 | 770 | 0.780 |
Why?
| | Sodium-Phosphate Cotransporter Proteins | 5 | 2011 | 10 | 0.740 |
Why?
| | Glomerulonephritis | 1 | 2020 | 45 | 0.710 |
Why?
| | Mice, Knockout | 6 | 2023 | 2570 | 0.600 |
Why?
| | Fluorescein-5-isothiocyanate | 2 | 2014 | 37 | 0.570 |
Why?
| | Potassium Channels, Voltage-Gated | 3 | 2004 | 48 | 0.570 |
Why?
| | Kidney | 7 | 2022 | 1188 | 0.560 |
Why?
| | Interleukin-6 | 2 | 2019 | 676 | 0.540 |
Why?
| | Actins | 3 | 2020 | 381 | 0.510 |
Why?
| | Animals | 26 | 2023 | 31706 | 0.500 |
Why?
| | Cells, Cultured | 8 | 2020 | 3886 | 0.500 |
Why?
| | Mice | 16 | 2023 | 14869 | 0.500 |
Why?
| | Albuminuria | 2 | 2013 | 164 | 0.470 |
Why?
| | Protein Transport | 5 | 2021 | 395 | 0.460 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIc | 2 | 2011 | 2 | 0.460 |
Why?
| | Caveolae | 1 | 2014 | 15 | 0.460 |
Why?
| | Magnesium | 1 | 2014 | 145 | 0.460 |
Why?
| | Kidney Glomerulus | 3 | 2019 | 100 | 0.420 |
Why?
| | Proteinuria | 3 | 2021 | 77 | 0.400 |
Why?
| | Myosin Heavy Chains | 2 | 2011 | 177 | 0.390 |
Why?
| | Signal Transduction | 4 | 2021 | 4513 | 0.370 |
Why?
| | Protein Interaction Mapping | 1 | 2011 | 101 | 0.350 |
Why?
| | Potassium Channels | 2 | 2001 | 121 | 0.330 |
Why?
| | Diabetic Nephropathies | 1 | 2012 | 234 | 0.320 |
Why?
| | Calcium | 2 | 2014 | 1108 | 0.320 |
Why?
| | Kidney Diseases | 2 | 2022 | 350 | 0.300 |
Why?
| | Cell Membrane | 4 | 2009 | 680 | 0.300 |
Why?
| | Transcytosis | 2 | 2021 | 8 | 0.300 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2012 | 486 | 0.280 |
Why?
| | Phosphorus, Dietary | 3 | 2011 | 4 | 0.260 |
Why?
| | Cell Line | 4 | 2021 | 2637 | 0.240 |
Why?
| | Apoptosis | 1 | 2013 | 2363 | 0.220 |
Why?
| | Proteolysis | 2 | 2014 | 142 | 0.220 |
Why?
| | Microvilli | 4 | 2011 | 70 | 0.220 |
Why?
| | Antigen-Antibody Complex | 1 | 2023 | 84 | 0.210 |
Why?
| | Inflammation | 1 | 2013 | 2480 | 0.200 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 4694 | 0.200 |
Why?
| | Hyperphosphatemia | 1 | 2022 | 14 | 0.200 |
Why?
| | Complement Factor H | 1 | 2022 | 60 | 0.200 |
Why?
| | Disease Models, Animal | 4 | 2021 | 3535 | 0.190 |
Why?
| | Sodium-Hydrogen Exchangers | 2 | 2011 | 21 | 0.190 |
Why?
| | Glomerular Filtration Rate | 2 | 2014 | 604 | 0.180 |
Why?
| | Glomerular Basement Membrane | 1 | 2020 | 7 | 0.180 |
Why?
| | Autophagy-Related Proteins | 1 | 2021 | 39 | 0.180 |
Why?
| | Cardiovascular Diseases | 1 | 2012 | 1727 | 0.180 |
Why?
| | Homeostasis | 3 | 2014 | 573 | 0.180 |
Why?
| | Opossums | 2 | 2011 | 10 | 0.180 |
Why?
| | Vascular Calcification | 1 | 2022 | 107 | 0.180 |
Why?
| | Focal Adhesions | 1 | 2020 | 42 | 0.170 |
Why?
| | Flow Cytometry | 2 | 2020 | 1083 | 0.170 |
Why?
| | Microscopy, Fluorescence | 3 | 2011 | 396 | 0.170 |
Why?
| | Nephrectomy | 1 | 2021 | 150 | 0.170 |
Why?
| | Lipocalins | 1 | 2019 | 34 | 0.170 |
Why?
| | Disease | 1 | 2020 | 85 | 0.170 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2004 | 801 | 0.160 |
Why?
| | Cell Line, Transformed | 1 | 2019 | 133 | 0.160 |
Why?
| | Allografts | 1 | 2019 | 122 | 0.160 |
Why?
| | Cytoskeleton | 2 | 2011 | 176 | 0.160 |
Why?
| | Neurons | 2 | 2004 | 1280 | 0.160 |
Why?
| | Phosphoproteins | 2 | 2011 | 298 | 0.160 |
Why?
| | Cell Adhesion Molecules | 1 | 2019 | 168 | 0.160 |
Why?
| | Autophagy | 1 | 2021 | 235 | 0.160 |
Why?
| | Ion Channel Gating | 1 | 1998 | 83 | 0.150 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2019 | 352 | 0.150 |
Why?
| | Membrane Proteins | 2 | 2022 | 1019 | 0.150 |
Why?
| | Shab Potassium Channels | 3 | 2004 | 18 | 0.150 |
Why?
| | Humans | 16 | 2022 | 114689 | 0.150 |
Why?
| | Xenopus | 3 | 2004 | 97 | 0.140 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 2 | 2014 | 29 | 0.130 |
Why?
| | Fibroblast Growth Factors | 2 | 2022 | 162 | 0.130 |
Why?
| | Cell Polarity | 2 | 2014 | 131 | 0.130 |
Why?
| | Biomarkers | 3 | 2019 | 3408 | 0.130 |
Why?
| | Epithelial Cells | 1 | 2021 | 951 | 0.120 |
Why?
| | Inflammation Mediators | 2 | 2021 | 477 | 0.120 |
Why?
| | Renal Reabsorption | 1 | 2014 | 4 | 0.120 |
Why?
| | Renal Elimination | 1 | 2014 | 6 | 0.120 |
Why?
| | Gastrointestinal Absorption | 1 | 2014 | 5 | 0.120 |
Why?
| | Losartan | 1 | 2014 | 9 | 0.120 |
Why?
| | Endothelial Cells | 1 | 2019 | 687 | 0.120 |
Why?
| | Lisinopril | 1 | 2014 | 13 | 0.120 |
Why?
| | Denys-Drash Syndrome | 1 | 2014 | 4 | 0.120 |
Why?
| | WT1 Proteins | 1 | 2014 | 12 | 0.120 |
Why?
| | Microscopy, Confocal | 2 | 2019 | 304 | 0.120 |
Why?
| | Mutation | 3 | 2020 | 3346 | 0.120 |
Why?
| | Metabolic Diseases | 1 | 2014 | 98 | 0.110 |
Why?
| | Ion Transport | 2 | 2011 | 55 | 0.110 |
Why?
| | Rats, Sprague-Dawley | 3 | 2014 | 2218 | 0.110 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2014 | 179 | 0.110 |
Why?
| | Protease Inhibitors | 1 | 2014 | 97 | 0.110 |
Why?
| | Vesicular Transport Proteins | 1 | 2014 | 83 | 0.110 |
Why?
| | Acute Kidney Injury | 1 | 2019 | 638 | 0.110 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type III | 2 | 2009 | 5 | 0.100 |
Why?
| | Fluorescence Resonance Energy Transfer | 2 | 2011 | 170 | 0.100 |
Why?
| | Caspases | 1 | 2013 | 245 | 0.100 |
Why?
| | Orphan Nuclear Receptors | 1 | 2011 | 14 | 0.100 |
Why?
| | Membrane Potentials | 2 | 2004 | 248 | 0.090 |
Why?
| | Repressor Proteins | 1 | 2014 | 366 | 0.090 |
Why?
| | Biological Transport, Active | 1 | 2011 | 71 | 0.090 |
Why?
| | Absorption | 1 | 2011 | 52 | 0.090 |
Why?
| | Green Fluorescent Proteins | 2 | 2004 | 371 | 0.090 |
Why?
| | Kinetics | 1 | 2014 | 1551 | 0.090 |
Why?
| | Cytokines | 2 | 2021 | 1841 | 0.090 |
Why?
| | Spectrometry, Fluorescence | 1 | 2011 | 157 | 0.090 |
Why?
| | Rats | 3 | 2014 | 4958 | 0.090 |
Why?
| | Hormones | 1 | 2011 | 132 | 0.090 |
Why?
| | Delayed Rectifier Potassium Channels | 2 | 2001 | 9 | 0.090 |
Why?
| | Recombinant Fusion Proteins | 2 | 2004 | 616 | 0.090 |
Why?
| | Genes, Dominant | 1 | 2009 | 94 | 0.080 |
Why?
| | Potassium Deficiency | 1 | 2009 | 1 | 0.080 |
Why?
| | Mice, Transgenic | 1 | 2014 | 1949 | 0.080 |
Why?
| | Aging | 1 | 2019 | 1618 | 0.080 |
Why?
| | NF-kappa B | 1 | 2013 | 641 | 0.080 |
Why?
| | Intestine, Small | 1 | 2009 | 122 | 0.080 |
Why?
| | Dopamine | 1 | 2011 | 236 | 0.080 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2011 | 386 | 0.080 |
Why?
| | RNA, Messenger | 4 | 2009 | 2553 | 0.080 |
Why?
| | Hypophosphatemia, Familial | 1 | 2006 | 3 | 0.070 |
Why?
| | Gene Expression Regulation | 2 | 2013 | 2320 | 0.070 |
Why?
| | Male | 5 | 2021 | 55599 | 0.070 |
Why?
| | Sodium-Bicarbonate Symporters | 1 | 2005 | 4 | 0.060 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2005 | 153 | 0.060 |
Why?
| | Angiotensin II | 1 | 2005 | 87 | 0.060 |
Why?
| | Gene Expression | 2 | 2001 | 1421 | 0.060 |
Why?
| | Protein Kinase C | 1 | 2005 | 273 | 0.060 |
Why?
| | Female | 3 | 2021 | 59511 | 0.050 |
Why?
| | Protein Structure, Tertiary | 1 | 2004 | 796 | 0.050 |
Why?
| | Spinal Cord | 1 | 2004 | 347 | 0.050 |
Why?
| | Kv1.1 Potassium Channel | 1 | 2001 | 7 | 0.050 |
Why?
| | Microinjections | 1 | 2001 | 76 | 0.050 |
Why?
| | Mechanistic Target of Rapamycin Complex 2 | 1 | 2021 | 55 | 0.050 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2021 | 96 | 0.040 |
Why?
| | Embryo, Nonmammalian | 1 | 2001 | 173 | 0.040 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2021 | 157 | 0.040 |
Why?
| | Patch-Clamp Techniques | 1 | 2001 | 239 | 0.040 |
Why?
| | Luminescent Proteins | 1 | 2001 | 166 | 0.040 |
Why?
| | Acute-Phase Proteins | 1 | 2019 | 64 | 0.040 |
Why?
| | Complement Activation | 1 | 2022 | 340 | 0.040 |
Why?
| | Lipocalin-2 | 1 | 2019 | 61 | 0.040 |
Why?
| | Complement System Proteins | 1 | 2022 | 283 | 0.040 |
Why?
| | Isoantibodies | 1 | 2019 | 57 | 0.040 |
Why?
| | Biological Transport | 2 | 2011 | 373 | 0.040 |
Why?
| | Models, Neurological | 1 | 2001 | 212 | 0.040 |
Why?
| | Risk Factors | 1 | 2012 | 8632 | 0.040 |
Why?
| | Antigen Presentation | 1 | 2019 | 188 | 0.040 |
Why?
| | Hepatocytes | 1 | 2019 | 195 | 0.040 |
Why?
| | Electrophysiology | 1 | 1998 | 201 | 0.040 |
Why?
| | Action Potentials | 1 | 2001 | 406 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 1 | 1998 | 345 | 0.040 |
Why?
| | Up-Regulation | 1 | 2019 | 808 | 0.030 |
Why?
| | Metabolomics | 1 | 2021 | 521 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 1998 | 1982 | 0.030 |
Why?
| | Molecular Sequence Data | 1 | 1998 | 2785 | 0.030 |
Why?
| | Creatinine | 1 | 2014 | 425 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2014 | 951 | 0.020 |
Why?
| | Liver X Receptors | 1 | 2011 | 30 | 0.020 |
Why?
| | Protein Stability | 1 | 2011 | 157 | 0.020 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIb | 1 | 2009 | 9 | 0.020 |
Why?
| | Enterocytes | 1 | 2009 | 14 | 0.020 |
Why?
| | Cytoplasmic Vesicles | 1 | 2009 | 12 | 0.020 |
Why?
| | Jejunum | 1 | 2009 | 24 | 0.020 |
Why?
| | Hypophosphatemia | 1 | 2009 | 15 | 0.020 |
Why?
| | Ligands | 1 | 2011 | 562 | 0.020 |
Why?
| | Duodenum | 1 | 2009 | 62 | 0.020 |
Why?
| | Adaptation, Physiological | 1 | 2011 | 483 | 0.020 |
Why?
| | Blotting, Western | 1 | 2009 | 1147 | 0.020 |
Why?
| | Intestinal Mucosa | 1 | 2011 | 532 | 0.020 |
Why?
| | Receptor, Angiotensin, Type 1 | 1 | 2005 | 20 | 0.020 |
Why?
| | Protein Binding | 1 | 2011 | 1890 | 0.020 |
Why?
| | Xenopus laevis | 1 | 2005 | 118 | 0.020 |
Why?
| | Oocytes | 1 | 2005 | 170 | 0.010 |
Why?
| | Transfection | 1 | 2005 | 866 | 0.010 |
Why?
| | Models, Biological | 1 | 2005 | 1621 | 0.010 |
Why?
|
|
Blaine's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|